Combination therapy with an angiotensin-converting-enzyme inhibitor and an angiotensin II receptor antagonist ameliorates microinflammation and oxidative stress in patients with diabetic nephropathy
2012 ◽
Vol 4
(2)
◽
pp. 195-201
◽
2010 ◽
Vol 44
(4)
◽
pp. 251-256
◽
1997 ◽
Vol 11
(1)
◽
pp. 53-62
◽
2000 ◽
Vol 20
(5)
◽
pp. 373-379
◽